Signaling pathways involved in glucocorticoid-induced apoptosis of thymocytes

Critical Reviews in Immunology

Volumn 25, Issue 4, 2005, Pages 263-288

  Lépine, Sandrine ^a   Sulpice, Jean Claude ^a,b   Giraud, Françoise ^a  

^a CNRS   (France)

^b UNIVERSITÉ PARIS SACLAY   (France)

Author keywords

Bcl 2 proteins; cdk2; Mitochondria; Phosphatidylserine; Protein kinase; Sphingolipids

Indexed keywords

CALCIUM ION; CASPASE; CERAMIDE; CYCLIN DEPENDENT KINASE 2; ENDONUCLEASE; GLUCOCORTICOID; GLUCOCORTICOID RECEPTOR; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; PHOSPHATIDYLSERINE; POTASSIUM ION; PROTEASOME; PROTEIN BCL 2; PROTEIN KINASE; PROTEIN KINASE C; REACTIVE OXYGEN METABOLITE; SODIUM ION; SPHINGOLIPID; SPHINGOSINE;

APOPTOSIS; CALCIUM CELL LEVEL; CELL NUCLEUS; DOWN REGULATION; ENZYME ACTIVATION; ENZYME ACTIVITY; MITOCHONDRION; NONHUMAN; PHAGOCYTOSIS; PRIORITY JOURNAL; PROTEIN FUNCTION; PROTEIN LOCALIZATION; REVIEW; SIGNAL TRANSDUCTION; THYMOCYTE; THYMUS; UPREGULATION;

ANIMALS; APOPTOSIS; GLUCOCORTICOIDS; HUMANS; MITOCHONDRIA; PROTO-ONCOGENE PROTEINS C-BCL-2; SIGNAL TRANSDUCTION; SPHINGOLIPIDS; THYMUS GLAND;

EID: 30444432353     PISSN: 10408401     EISSN: None     Source Type: Journal    
DOI: 10.1615/CritRevImmunol.v25.i4.20     Document Type: Review

References (142)

1. Sprent J, Webb SR. Function and specificity of T cell subsets in the mouse. Adv Immunol. 1987;41:39-133.
2. Cinque B, Di Marzio L, Centi C, Di Rocco C, Riccardi C, Grazia Cifone M. Sphingolipids and the immune system. Pharmacol Res. 2003;47:421-37.
3. Purton JF, Zhan Y, Liddicoat DR, Hardy CL, Lew AM, Cole TJ, Godfrey DI. Glucocorticoid receptor deficient thymic and peripheral T cells develop normally in adult mice. Eur J Immunol. 2002;32:3546-55.
4. Petit PX, Lecoeur H, Zorn E, Dauguet C, Mignotte B, Gougeon ML. Alterations in mitochondrial structure and function are early events of dexamethasone-induced thymocyte apoptosis. J Cell Biol. 1995;130:157-67.
5. Castedo M, Hirsch T, Susin SA, Zamzami N, Marchetti P, Macho A, Kroemer G. Sequential acquisition of mitochondrial and plasma membrane alterations during early lymphocyte apoptosis. J Immunol. 1996;157:512-21.
6. Waring P, Lambert D, Sjaarda A, Hurne A, Beaver J. Increased cell surface exposure of phosphatidylserine on propidium iodide negative thymocytes undergoing death by necrosis. Cell Death Differ. 1999;6:624-37.
7. Mann CL, Hughes FM Jr, Cidlowski JA. Delineation of the signaling pathways involved in glucocorticoid-induced and spontaneous apoptosis of rat thymocytes. Endocrinology. 2000;141:528-38.
8. Wiegers GJ, Knoflach M, Bock G, Niederegger H, Dietrich H, Falus A, Boyd R, Wick G. CD4(+)CD8(+) TCR(low) thymocytes express low levels of glucocorticoid receptors while being sensitive to glucocorticoid-induced apoptosis. Eur J Immunol. 2001;31:2293-301.
9. van den Brandt J, Wang D, Reichardt HM. Resistance of single-positive thymocytes to glucocorticoid-induced apoptosis is mediated by CD28 signaling. Mol Endocrinol. 2004;18:687-95.
10. Fadok VA, Bratton DL, Rose DM, Pearson A, Ezekewitz RA, Henson PM. A receptor for phosphatidylserine-specific clearance of apoptotic cells. Nature. 2000;405:85-90.
11. Distelhorst CW. Recent insights into the mechanism of glucocorticosteroid-induced apoptosis. Cell Death Differ. 2002;9:6-19.
12. Grimm LM, Goldberg AL, Poirier GG, Schwarz LM, Osborne BA. Proteasome plays an essential role in thymocyte apoptosis. EMBO J. 1996;15:3835-44.
13. Wallace AD, Cidlowski JA. Proteasome-mediated glucocorticoid receptor degradation restricts transcriptional signaling by glucocorticoids. J Biol Chem. 2001;276:42714-21.
14. Hakem A, Sasaki T, Kozieradzki I, Penninger JM. The cyclin-dependent kinase Cdk2 regulates thymocyte apoptosis. J Exp Med. 1999;189:957-68.
15. Vacchio MS, Ashwell JD. Glucocorticoids and thymocyte development. Semin Immunol. 2000;12:475-85.
16. Winoto A, Littman DR. Nuclear hormone receptors in T lymphocytes. Cell. 2002;109:S57-66.
17. Marchetti MC, Di Marco B, Santini M, Bartoli A, Delfino D, Riccardi C. Dexamethasone-induced thymocytes apoptosis requires glucocorticoid receptor nuclear translocation but not mitochondrial potential transition. Toxicol Lett. 2003;139:175-80.
18. Cifone MG, Migliorati G, Parroni R, Marchetti C, Millimaggi D, Santoni A, Riccardi C. Dexamethasone-induced thymocyte apoptosis: apoptotic signal involves the sequential activation of phosphoinositide-specific phospholipase C, acidic sphingomyelinase, and caspases. Blood. 1999;93:2282-96.
19. Schaaf MJ, Cidlowski JA. Molecular mechanisms of glucocorticoid action and resistance. J Steroid Biochem Mol Biol. 2002;83:37-48.
20. Dallaporta B, Hirsch T, Susin SA, Zamzami N, Larochette N, Brenner C, Marzo I, Kroemer G. Potassium leakage during the apoptotic degradation phase. J Immunol. 1998;160:5605-15.
21. Mann CL, Cidlowski JA. Glucocorticoids regulate plasma membrane potential during rat thymocyte apoptosis in vivo and in vitro. Endocrinology. 2001;142:421-9.
22. Mann CL, Bortner CD, Jewell CM, Cidlowski JA. Glucocorticoid-induced plasma membrane depolarization during thymocyte apoptosis: association with cell shrinkage and degradation of the Na(+)/K(+)-adenosine triphosphatase. Endocrinology. 2001;142:5059-68.
23. Marchetti C, Di Marco B, Cifone MG, Riccardi C. Dexamethasone-induced apoptosis of thymocytes: role of glucocortocoid receptor-associated Src kinase and caspase-8 activation. Blood. 2003;101:585-93.
24. Granes F, Roig MB, Brady HJ, Gil-Gomez G. Cdk2 activation acts upstream of the mitochondrion during glucocorticoid induced thymocyte apoptosis. Eur J Immunol. 2004;34:2781-90.
25. D'Adamio F, Zollo O, Moraca R, Ayroldi E, Bruscoli S, Bartoli A, Cannarile L, Migliorati G, Riccardi C. A new dexamethasone-induced gene of the leucine zipper family protects T lymphocytes from TCR/CD3-activated cell death. Immunity. 1997;7:803-12.
26. Delfino DV, Agostini M, Spinicelli S, Vito P, Riccardi C. Decrease of Bcl-xL and augmentation of thymocyte apoptosis in GILZ overexpressing transgenic mice. Blood. 2004;104:4134-41.
27. Ayroli E, Migliorati G, Bruscoli S, Marchetti C, Zollo O, Cannarile L, D'Adamio F, Riccardi C. Modulation of T-cell activation by the glucocorticoid-induced leucine zipper factor via inhibition of nuclear factor κB. Blood. 2001;98:743-53.
28. Voll RE, Jimi E, Phillips RJ, Barber DF, Rincon M, Hayday AC, Flavell RA, Ghosh S. NF-κB activation by the pre-T cell receptor serves as a selective survival signal in T lymphocyte development. Immunity. 2000;13:677-89.
29. Kasibhatla S, Brunner T, Genstier L, Mahboubi A, Green DR. DNA damaging agents induce expression of Fas ligand and subsequent apoptosis in T lymphocytes via the activation of NF-kappaB and AP-1. Mol Cell. 1998;1:543-51.
30. Huwiler A, Kolter T, Pfeilschifter J, Sandhoff K. Physiology and pathophysiology of sphingolipid metabolism and signaling. Biochim Biophys Acta. 2000;1485:63-99.
31. Hannun YA, Luberto C. Lipid metabolism: ceramide transfer protein adds a new dimension. Curr Biol. 2004;14:R163-5.
32. Pettus BJ, Chalfant CE, Hannun YA. Ceramide in apoptosis: an overview and current perspectives. Biochim Biophys Acta. 2002;1585:114-25.
33. Cuvillier O. Sphingosine in apoptosis signaling. Biochim Biophys Acta. 2002;1585:153-62.
34. Spiegel S, Milstien S. Sphingosine-1-phosphate: an enigmatic signalling lipid. Nat Rev Mol Cell Biol. 2003;4:397-407.
35. Ruvolo PP. Intracellular signal transduction pathways activated by ceramide and its metabolites. Pharmacol Res. 2003;47:383-92.
36. Lepine S, Lakatos B, Courageot MP, Le Stunff H, Sulpice JC, Giraud F. Sphingosine contributes to glucocorticoid-induced apoptosis of thymocytes independently of the mitochondrial pathway. J Immunol. 2004;173:3783-90.
37. Green DR, Reed JC. Mitochondria and apoptosis. Science. 1998;281:1309-12.
38. Kroemer G, Reed JC. Mitochondrial control of cell death. Nat Med. 2000;6:513-9.
39. Zamzami N, Kroemer G. The mitochondrion in apoptosis: how Pandora's box opens. Nat Rev Mol Cell Biol. 2001;2:67-71.
40. Yoshino T, Kishi H, Nagata T, Tsukada K, Saito S, Muraguchi A. Differential involvement of p38 MAP kinase pathway and Bax translocation in the mitochondria-mediated cell death in TCR- and dexamethasone-stimulated thymocytes. Eur J Immunol. 2001;31:2702-8.
41. Marchetti P, Castedo M, Susin SA, Zamzami N, Hirsch T, Macho A, Haeffher A, Hirsch F, Geuskens M, Kroemer G. Mitochondrial permeability transition is a central coordinating event of apoptosis. J Exp Med. 1996;184:1155-60.
42. Hoijman E, Rocha Viegas L, Keller Sarmiento MI, Rosenstein RE, Pecci A. Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Endocrinology. 2004;145:418-25.
43. Sade H, Khandre NS, Mathew MK, Sarin A. The mitochondrial phase of the glucocorticoid-induced apoptotic response in thymocytes comprises sequential activation of adenine nucleotide transporter (ANT)-independent and ANT-dependent events. Eur J Immunol. 2004;34:119-25.
44. McLaughlin KA, Osborne BA, Goldsby RA. The role of oxygen in thymocyte apoptosis. Eur J Immunol. 1996;26:1170-4.
45. Tonomura N, McLaughlin K, Grimm LM, Goldsby RA, Osborne BA. Glucocorticoid-induced apoptosis of thymocytes: requirement of proteasome-dependent mitochondrial activity. J Immunol. 2003;170:2469-78.
46. Torres-Roca JF, Tung JW, Greenwald DR, Brown JM, Herzenberg LA, Katsikis PD. An early oxygen-dependent step is required for dexamethasone-induced apoptosis of immature mouse thymocytes. J Immunol. 2000;165:4822-30.
47. Beaver JP, Waring P. A decrease in intracellular glutathione concentration precedes the onset of apoptosis in murine thymocytes. Eur J Cell Biol. 1995;68:47-54.
48. Marchetti P, Decaudin D, Macho A, Zamzami N, Hirsch T, Susin SA, Kroemer G. Redox regulation of apoptosis: impact of thiol oxidation status on mitochondrial function. Eur J Immunol. 1997;27:289-96.
49. Tome ME, Baker AF, Powis G, Payne CM, Briehl MM. Catalase-overexpressing thymocytes are resistant to glucocorticoid-induced apoptosis and exhibit increased net tumor growth. Cancer Res. 2001;61:2766-73.
50. Fernandez A, Kiefer J, Fosdick L, McConkey DJ. Oxygen radical production and thiol depletion are required for Ca(2+)-mediated endogenous endonuclease activation in apoptotic thymocytes. J Immunol. 1995;155:5133-9.
51. Macho A, Hirsch T, Marzo I, Marchetti P, Dallaporta B, Susin SA, Zamzami N, Kroemer G. Glutathione depletion is an early and calcium elevation is a late event of thymocyte apoptosis. J Immunol. 1997;158:4612-9.
52. Ramakrishnan N, Chen R, McClain DE, Bunger R. Pyruvate prevents hydrogen peroxide-induced apoptosis. Free Radic Res. 1998;29:283-95.
53. Crompton M. The mitochondrial permeability transition pore and its role in cell death. Biochem J. 1999;341:233-49.
54. Fadeel B, Zhivotovsky B, Orrenius S. All along the watchtower: on the regulation of apoptosis regulators. FASEB J. 1999;13:1647-57.
55. Antonsson B, Martinou JC. The Bcl-2 protein family. Exp Cell Res. 2000;256:50-7.
56. Linette GP, Grusby MJ, Hedrick SM, Hansen TH, Glimcher LH, Korsmeyer SJ. Bcl-2 is upregulated at the CD4+ CD8+ stage during positive selection and promotes thymocyte differentiation at several control points. Immunity. 1994;1:197-205.
57. Ma A, Pena JC, Chang B, Margosian E, Davidson L, Alt FW, Thompson CB. Bclx regulates the survival of double-positive thymocytes. Proc Natl Acad Sci U S A. 1995;92:4763-7.
58. Sentman CL, Shutter JR, Hockenbery D, Kanagawa O, Korsmeyer SJ. bcl-2 inhibits multiple forms of apoptosis but not negative selection in thymocytes. Cell. 1991;67:879-88.
59. Bouillet P, Metcalf D, Huang DC, Tarlinton DM, Kay TW, Kontgen F, Adams JM, Strasser A. Proapoptotic Bcl-2 relative Bim required for certain apoptotic responses, leukocyte homeostasis, and to preclude autoimmunity. Science. 1999;86:1735-8.
60. Mok CL, Gil-Gomez G, Williams O, Coles M, Taga S, Tolaini M, Norton T, Kioussis D, Brady HJ. Bad can act as a key regulator of T cell apoptosis and T cell development. J Exp Med. 1999;189:575-86.
61. Hsu YT, Wolter KG, Youle RJ. Cytosol-to-membrane redistribution of Bax and Bcl-X(L) during apoptosis. Proc Natl Acad Sci U S A. 1997;94:3668-72.
62. Li H, Zhu H, Xu CJ, Yuan J. Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell. 1998;94:491-501.
63. Brady HJ, Salomons GS, Bobeldijk RC, Berns AJ. T cells from baxalpha transgenic mice show accelerated apoptosis in response to stimuli but do not show restored DNA damage-induced cell death in the absence of p53. gene product in. EMBO J. 1996;15:1221-30.
64. Rathmell JC, Lindsten T, Zong WX, Cinalli RM, Thompson CB. Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol. 2002;3:932-9.
65. Marsden VS, O'Connor L, O'Reilly LA, Silke J, Metcalf D, Ekert PG, Huang DC, Cecconi F, Kuida K, Tomaselli KJ, Roy S, Nicholson DW, Vaux DL, Bouillet P, Adams JM, Strasser A. Apoptosis initiated by Bcl-2-regulated caspase activation independently of the cytochrome c/Apaf-1/caspase-9 apoptosome. Nature. 2002;419:634-7.
66. Adams J. The proteasome: structure, function, and role in the cell. Cancer Treat Rev. 2003;29:3-9.
67. Yang Y, Yu X. Regulation of apoptosis: the ubiquitous way. FASEB J. 2003;17:790-9.
68. Hirsch T, Dallaporta B, Zamzami N, Susin SA, Ravagnan L, Marzo I, Brenner C, Kroemer G. Proteasome activation occurs at an early, premitochondrial step of thymocyte apoptosis. J Immunol. 1998;161:35-40.
69. Dallaporta B, De Pablo M, Maisse C, Daugas E, Loeffer M, Zamzami N, Kroemer G. Proteasome activation as a critical event of thymocyte apoptosis. Cell Death Differ. 2000;7:368-73.
70. Beyette J, Mason GG, Murray RZ, Cohen GM, Rivett AJ. Proteasome activities decrease during dexamethasone-induced apoptosis of thymocytes. Biochem J. 1998;332:315-20.
71. Vugmeyster Y, Borodovsky A, Maurice MM, Maehr R, Furman MH, Ploegh HL. The ubiquitin-proteasome pathway in thymocyte apoptosis: caspase-dependent processing of the deubiquitinating enzyme USP7 (HAUSP). Mol Immunol. 2002;39:431-41.
72. Marshansky V, Wang X, Bertrand R, Luo H, Duguid W, Chinnadurai G, Kanaan N, Vu MD, Wu J. Proteasomes modulate balance among proapoptotic and antiapoptotic Bcl-2 family members and compromise functioning of the electron transport chain in leukemic cells. J Immunol. 2001;166:3130-42.
73. Li B, Dou QP. Bax degradation by the ubiquitin/proteasome-dependent pathway: involvement in tumor survival and progression. Proc Natl Acad Sci U S A. 2000;97:3850-5.
74. Gil-Gomez G, Berns A, Brady HJ. A link between cell cycle and cell death: Bax and Bcl-2 modulate Cdk2 activation during thymocyte apoptosis. EMBO J. 1998;17:7209-18.
75. Linette GP, Li Y, Roth K, Korsmeyer SJ. Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. Proc Natl Acad Sci USA. 1996;93:9545-52.
76. Meijer L, Kim SH. Chemical inhibitors of cyclin-dependent kinases. Methods Enzymol. 1997;283:113-28.
77. van Engeland M, Kuijpers HJ, Ramaekers FC, Reutelingsperger CP, Schutte B. Plasma membrane alterations and cytoskeletal changes in apoptosis. Exp Cell Res. 1997;235:421-30.
78. Pagano M, Tam SW, Theodoras AM, Beer-Romero P, Del Sal G, Chau V, Yew PR, Draetta GF, Rolfe M. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27. Science. 1995;269:682-5.
79. Degterev A, Boyce M, Yuan J. A decade of caspases. Oncogene. 2003;22:8543-67.
80. Komoriya A, Packard BZ, Brown MJ, Wu M, Henkart PA. Assessment of caspase acivities in intact apoptotic thymocytes using cell-permeable fluorogenic caspase substrates. J Exp Med. 2000;191:1819-28.
81. Kuida K, Haydar TF, Kuan CY, Gu Y, Taya C, Karasuyama H, Su MS, Rakic P, Flavell RA. Reduced apoptosis and cytochrome c-mediated caspase activation in mice lacking caspase 9. Cell. 1998;94:325-37.
82. Yoshida H, Kong YY, Yoshida R, Elia AJ, Hakem A, Hakem R, Penninger JM, Mak TW. Apaf1 is required for mitochondrial pathways of apoptosis and brain development. Cell. 1998;94:739-50.
83. Hueber A, Bernard A, Herincs Z, Couzinet A, He H. An essential role for membrane rafts in the initiation of Fas/CD95-triggered cell death in mouse thymocytes. EMBO Rep. 2002;3:190-6.
84. Micheau O, Solary E, Hammann A, Dimanche-Boitrel MT. Fas ligand-independent, FADD-mediated activation of the Fas death pathway by anticancer drugs. J Biol Chem. 1999;274:7987-92.
85. Yin XM, Wang K, Gross A, Zhao Y, Zinkel S, Klocke B, Roth KA, Korsmeyer SJ. Bid-deficient mice are resistant to Fas-induced hepatocellular apoptosis. Nature. 1999;400:886-91.
86. Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene. 2003;22:8568-80.
87. Yang Y, Fang S, Jensen JP, Weissman AM, Ashwell JD. Ubiquitin protein ligase activity of IAPs and their degradation in proteasomes in response to apoptotic stimuli. Science. 2000;288:874-7.
88. Wada T, Penninger JM. Stress kinase MKK7: savior of cell cycle arrest and cellular senescence. Cell Cycle. 2004;3:577-9.
89. Fruman DA. Phosphoinositide 3-kinase and its targets in B-cell and T-cell signaling. Curr Opin Immunol. 2004;16:314-20.
90. Tan SL, Parker PJ. Emerging and diverse roles of protein kinase C in immune cell signalling. Biochem J. 2003;376:545-52.
91. Liu Y, Fiskum G, Schubert D. Generation of reactive oxygen species by the mitochondrial electron transport chain. J Neurochem. 2002;80:780-7.
92. Testolin L, Carson C, Wang Y, Walker PR, Armato U, Sikorska M. Jun and JNK kinase are activated in thymocytes in response to VM26 and radiation but not glucocorticoids. Exp Cell Res. 1997;230:220-32.
93. Jamieson CA, Yamamoto KR. Crosstalk pathway for inhibition of glucocorticoid-induced apoptosis by T cell receptor signaling. Proc Natl Acad Sci USA. 2000;97:7319-24.
94. Ayroldi E, Zollo O, Macchiarulo A, Di Marco B, Marchetti C, Riccardi C. Glucocorticoid-induced leucine zipper inhibits the Raf-extracellular signal-regulated kinase pathway by binding to Raf-1. Mol Cell Biol. 2002;22:7929-41.
95. Zundel W, Giaccia A. Inhibition of the anti-apoptotic PI(3)K/Akt/Bad pathway by stress. Genes Dev. 1998;12:1941-6.
96. Ghosh Choudhury G, Zhang JH, Ghosh-Choudhury N, Abboud HE. Ceramide blocks PDGF-induced DNA synthesis in mesangial cells via inhibition of Akt kinase in the absence of apoptosis. Biochem Biophys Res Commun. 2001;286:1183-90.
97. Franke TF, Cantley LC. Apoptosis. A Bad kinase makes good. Nature. 1997;390:116-7.
98. Rizzuto R, Pinton P, Ferrari D, Chami M, Szabadkai G, Magalhaes PJ, Di Virgilio F, Pozzan T. Calcium and apoptosis: facts and hypotheses. Oncogene. 2003;22:8619-27.
99. Asada A, Zhao Y, Kondo S, Iwata M. Induction of thymocyte apoptosis by Ca2+-independent protein kinase C (nPKC) activation and its regulation by calcineurin activation. J Biol Chem. 1998;273:28392-8.
100. Rennecke J, Richter KH, Haussermann S, Stempka L, Strand S, Stohr M, Marks F. Biphasic effect of protein kinase C activators on spontaneous and glucocorticoid-induced apoptosis in primary mouse thymocytes. Biochim Biophys Acta. 2000;1497:289-96.
101. Ye X, Georgoff I, Fleisher S, Coffman FD, Cohen S, Fresa KL. The mechanism of epipodophyllotoxin-induced thymocyte apoptosis: possible role of a novel Ca(2+)-independent protein kinase. Cell Immunol. 1993;151:320-35.
102. Iwata M, Iseki R, Sato K, Tozawa Y, Ohoka Y. Involvement of protein kinase C-epsilon in glucocorticoid-induced apoptosis in thymocytes. Int Immunol. 1994;6:431-8.
103. Ohoka Y, Kuwata T, Asada A, Zhao Y, Mukai M, Iwata M. Regulation of thymocyte lineage commitment by the level of classical protein kinase C activity. J Immunol. 1997;158:5707-16.
104. Baumann CA, Badamchian M, Goldstein AL. Thymosin alpha 1 antagonizes dexamethasone and CD3-induced apoptosis of CD4+ CD8+ thymocytes through the activation of cAMP and protein kinase C dependent second messenger pathways. Mech Aging Dev. 1997;94:85-101.
105. Ohta H, Yatomi Y, Sweeney EA, Hakomori S, Igarashi Y. A possible role of sphingosine in induction of apoptosis by tumor necrosis factor-alpha in human neutrophils. FEBS Lett. 1994;355:267-70.
106. Hamaguchi A, Suzuki E, Murayama K, Fujimura T, Hikita T, Iwabuchi K, Handa K, Withers DA, Masters SC, Fu H, Hakomori S. A sphingosine-dependent protein kinase that specifically phosphorylates 14-3-3 (SDK1) is identified as the kinase domain of PKCdelta: a preliminary note. Biochem Biophys Res Commun. 2003;307:589-94.
107. Bourbon NA, Yun J, Kester M. Ceramide directly activates protein kinase C zeta to regulate a stress-activated protein kinase signaling complex. J Biol Chem. 2000;275:35617-23.
108. Ko M, Ahn J, Lee C, Chung H, Jeon SH, Chung HY, Seong RH. E2A/HEB and IdS proteins control the sensitivity to glucocorticoid-induced apoptosis in thymocytes by regulating the SRG3 expression. J Biol Chem. 2004;279:21916-23.
109. Bortner CD, Cidlowski JA. Uncoupling cell shrinkage from apoptosis reveals that Na+ influx is required for volume loss during programmed cell death. J Biol Chem. 2003;278:39176-84.
110. Yu SP, Canzoniero LM, Choi DW. Ion homeostasis and apoptosis. Curr Opin Cell Biol. 2001;13:405-11.
111. Hughes FM Jr, Cidlowski JA. Glucocorticoid-induced thymocyte apoptosis: protease-dependent activation of cell shrinkage and DNA degradation. J Steroid Biochem Mol Biol. 1998;65:207-17.
112. Hughes FM Jr, Bortner CD, Purdy GD, Cidlowski JA. Intracellular K+ suppresses the activation of apoptosis in lymphocytes. J Biol Chem. 1997;272:30567-76.
113. Dallaporta B, Marchetti P, de Pablo MA, Maisse C, Duc HT, Metivier D, Zamzami N, Geuskens M, Kroemer G. Plasma membrane potential in thymocyte apoptosis. J Immunol. 1999;162:6534-42.
114. Sarkadi B, Cheung R, Mack E, Grinstein S, Gelfand EW, Rothstein A. Cation and anion transport pathways in volume regulatory response of human lymphocytes to hyposmotic media. Am J Physiol. 1985;248:C480-7.
115. Grinstein S, Clarke CA, Dupre A, Rothstein A. Volume-induced increase of anion permeability in human lymphocytes. J Gen Physiol. 1982;80:801-23.
116. Bortner CD, Hughes FM Jr, Cidlowski JA. A primary role for K+ and Na+ efflux in the activation of apoptosis. J Biol Chem. 1997;272:32436-42.
117. McCarthy JV, Cotter TG. Cell shrinkage and apoptosis: a role for potassium and sodium ion efflux. Cell Death Differ. 1997;4:756-70.
118. Courageot MP, Lepine S, Hours M, Giraud F, Sulpice JC. Involvement of sodium in early phosphatidylserine exposure and phospholipid scrambling induced by P2X7 purinoceptor activation in thymocytes. J Biol Chem. 2004;279:21815-23.
119. McConkey DJ, Orrenius S. The role of calcium in the regulation of apoptosis. J Leukoc Biol. 1996;59:775-83.
120. Boehning D, Patterson RL, Sedaghat L, Glebova NO, Kurosaki T, Snyder SH. Cytochrome c binds to inositol (1,4,5) trisphosphate receptors, amplifying calcium-dependent apoptosis. Nat Cell Biol. 2003;5:1051-61.
121. Kaiser N, Edelman IS. Calcium dependence of glucocorticoid-induced lymphocytolysis. Proc Natl Acad Sci U S A. 1977;74:638-42.
122. McConkey DJ, Nicotera P, Hartzell P, Bellomo G, Wyllie AH, Orrenius S. Glucocorticoids activate a suicide process in thymocytes through an elevation of cytosolic Ca2+ concentration. Arch Biochem Biophys. 1989;269:365-70.
123. Chvatchko Y, Valera S, Aubry JP, Renno T, Buell G, Bonnefoy JY. The involvement of an ATP-gated ion channel, P(2X1), in thymocyte apoptosis. Immunity. 1996;5:275-83.
124. Cohen JJ, Duke RC. Glucocorticoid activation of a calcium-dependent endonuclease in thymocyte nuclei leads to cell death. J Immunol. 1984;132:38-42.
125. Fadok VA, Bratton DL, Frasch SC, Warner ML, Henson PM. The role of phosphatidylserine in recognition of apoptotic cells by phagocytes. Cell Death Differ. 1998;5:551-62.
126. Martin SJ, Finucane DM, Amarante-Mendes GP, O'Brien GA, Green DR Phosphatidylserine externalization during CD95-induced apoptosis of cells and cytoplasts requires ICE/CED-3 protease activity. J Biol Chem. 1996;271:287S3-6.
127. Seigneuret M, Devaux PF. ATP-dependent asymmetric distribution of spin-labeled phospholipids in the erythrocyte membrane: relation to shape changes. Proc Natl Acad Sci USA. 1984;81:3751-5.
128. Zwaal RF, Schroit AJ. Pathophysiologic implications of membrane phospholipid asymmetry in blood cells. Blood. 1997;89:1121-32.
129. Williamson P, Kulick A, Zachowski A, Schlegel RA, Devaux PF. Ca2+ induces transbilayer redistribution of all major phospholipids in human erythrocytes. Biochemistry. 1992;31:6355-60.
130. Verhoven B, Schlegel RA, Williamson P. Mechanisms of phosphatidylserine exposure, a phagocyte recognition signal, on apoptotic T lymphocytes. J Exp Med. 1995;182:1597-601.
131. Sulpice JC, Zachowski A, Devaux PF, Giraud F. Requirement for phosphatidylinositol 4,5-bisphosphate in the Ca(2+)-induced phospholipid redistribution in the human erythrocyte membrane. J Biol Chem. 1994;269:6347-54.
132. Bucki R, Giraud F, Sulpice JC. Phosphatidylinositol 4,5-bisphosphate domain inducers promote phospholipid transverse redistribution in biological membranes. Biochemistry. 2000;39:5838-44.
133. Bratton DL, Fadok VA, Richter DA, Kailey JM, Guthrie LA, Henson PM. Appearance of phosphatidylserine on apoptotic cells requires calcium-mediated nonspecific flip-flop and is enhanced by loss of the aminophospholipid translocase. J Biol Chem. 1997;272:26159-65.
134. Maderna P, Godson C. Phagocytosis of apoptotic cells and the resolution of inflammation. Biochim Biophys Acta. 2003;1639:141-51.
135. Hong J, Lin G, Lin C, Wang W, Lee C, Lin T, Wu J. Phosphatidylserine receptor is required for the engulfment of dead apoptotic cells and for normal embryonic developement in zebrafish. Development. 2004;131:5417-27.
136. Li MO, Sarkisian MR, Mehal WZ, Rakic P, Flavell RA. Phosphatidylserine receptor is required for clearance of apoptotic cells. Science. 2003;302:1560-3.
137. Martin SJ, Reutelingsperger CP, McGahon AJ, Rader JA, van Schie RC, LaFace DM, Green DR. Early redistribution of plasma membrane phosphatidylserine is a general feature of apoptosis regardless of the initiating stimulus: inhibition by overexpression of Bcl-2 and Abl. J Exp Med. 1995;182:1545-56.
138. Stuart MC, Damoiseaux JG, Frederik PM, Arends JW, Reutelingsperger CP. Surface exposure of phosphatidylserine during apoptosis of rat thymocytes precedes nuclear changes. Eur J Cell Biol. 1998;76:77-83.
139. Chan A, Reiter R, Wiese S, Fertig G, Gold R. Plasma membrane phospholipid asymmetry precedes DNA fragmentation in different apoptotic cell models. Histochem Cell Biol. 1998;110:553-8.
140. Basse F, Stout JG, Sims PJ, Wiedmer T. Isolation of an erythrocyte membrane protein that mediates Ca2+-dependent transbilayer movement of phospholipid. J Biol Chem. 1996;271:17205-10.
141. Tomasiak MM, Stelmach H, Bodzenta-Lukaszyk A, Tomasiak M. Involvement of Na+/H+ exchanger in desmopressin-induced platelet procoagulant response. Acta Biochim Pol. 2004;51:773-88.
142. Kagan VE, Borisenko GG, Tyurina YY, Tyurin VA, Jiang J, Potapovich AI, Kini V, Amoscato AA, Fujii Y. Oxidative lipidomics of apoptosis: redox catalytic interactions of cytochrome c with cardiolipin and phosphatidyiserine. Free Radic Biol Med. 2004;37:1963-85.